Opella achieves global certification, redefining leadership in self-care

June 26, 2025 | 14:00
(0) user say
France-headquartered Opella announced on June 26 that it is the first global consumer healthcare company to achieve B Corp certification, after meeting the rigorous social and environmental standards set by B Lab, the nonprofit behind the certification.

This achievement marks a milestone on Opella’s journey to deliver responsible self-care for people and the planet.

This certification follows an intensive four-year transformation effort, during which Opella has redefined its approach to sustainability, innovation, and governance across its global operations. The company has demonstrated a strong performance in key areas including climate action, product sustainability, community health, and accountability at leadership level.

Julie Van Ongevalle, Opella president and CEO, shared, Being B Corp certified globally is a first step on our sustainability journey. We owe it to the incredible work done by our 11,000 employees across the globe, our customers, and our consumers. It is a commitment to redefine self-care by proving that business success and sustainability can and must go hand in hand.

Marissa Saretsky, chief sustainability officer, added, This recognition reflects the ambition that drives us forward. Going through the certifying process has been an amazing catalyst to drive our sustainability transformation, spur innovation, and engage our employees. It sets a global benchmark, and we are committed to leading from the front by turning high standards into everyday action. This is just the beginning.

Opella achieves global certification, redefining leadership in self-care
Opella Vietnam’s factory in Ho Chi Minh City. Photo: Opella

Key achievements include a 64 per cent reduction in Scope 1 and 2 greenhouse gas emissions since 2019 and sourcing over 93 per cent of Opella's electricity from renewable sources. As of 2024, 97 per cent of Opella’s paper-based packaging comes from certified or recycled materials.

Additionally, since 2022, Opella’s partnership with local non-governmental organisations on community programmes has directly benefited over one million people, and in 2024 alone, its educational campaigns on health awareness and responsible use of medicine reached over 129 million individuals.

Opella joins a community of committed companies and encourages more self-care players to join the journey towards greater responsibility and impact. Looking ahead, Opella views B Corp certification as a dynamic framework for continued progress. Its commitment to recertify regularly ensures the company remains focused on advancing innovative, inclusive, and measurable solutions for a healthy society and planet.

Opella achieves global certification, redefining leadership in self-care
Opella and its annual school cleaning day. Photo: Opella

B Lab is a nonprofit transforming the global economy to benefit all people, communities, and the planet. A leader in economic systems change, its global network creates standards, policies, tools, and programmes for business, and certifies companies, known as B Corps, who are leading the way. To date, its community includes 950,000 workers in over 9,600 B Corps across 102 countries and 161 industries.

Opella is the self-care challenger with the purest and third-largest portfolio in the over-the-counter vitamins, minerals, and supplements market globally.

At the core of this mission is its 100 loved brands, 11,000-strong global team, 13 best-in-class manufacturing sites and four specialised science and innovation development centres. Headquartered in France, Opella is the proud maker of many of the world’s most loved brands, including Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale, and Mucosolvan.

In Vietnam, Opella is known for Enterogermina, Lactacyd, Calcium Corbière, Pharmaton, and Phosphalugel. Opella has offices in Ho Chi Minh City and Hanoi, and a manufacturing site with advanced and automated technology in Saigon Hi Tech Park with Australia’s TGA and Korea’s MFDS - GMP certificates. Vietnam is also home to the only research and development centre of Opella in Asia, one of four worldwide. Its products are exported to 13 countries.

Opella launches as independent company Opella launches as independent company

Healthcare group Opella on May 8 announced that it is now a standalone company after Sanofi completed the closing of the sale of 50 per cent of the controlling stake of Opella to CD&R.

Medscape sets up in Australia to boost healthcare innovation Medscape sets up in Australia to boost healthcare innovation

The global medical education leader strengthens its regional footprint to better support practitioners and patients.

SpaceX seeks opportunities in Vietnam’s healthcare sector SpaceX seeks opportunities in Vietnam’s healthcare sector

American space technology company SpaceX is planning to expand its presence in Vietnam by seeking opportunities in the healthcare sector, which is accelerating digital transformation.

Portfolio overhauls illustrate Vietnam’s potential Portfolio overhauls illustrate Vietnam’s potential

Vietnam’s healthcare and pharmaceutical market has become heated as investors step up the restructuring of their investment portfolios.

By Bich Thuy

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional